Effects of sodium-glucose co-transporter inhibitors on individual clinical endpoints and quality of life.
Liao J, Chen Y, Ling Z, Pürerfellner H, Martinek M, Derndorfer M, Niel J, Ebrahimi R, Heukäufer M, Janschel S, Di Vece D, Empen K, Hummel A, Chamling B, Futyma P, Ebrahimi F, Kiuchi MG, Liu S, Yin Y, Schratter A, Acou WJ, Sommer P, Schmidt B, Chun JKR, Meyer C, Dörr M, Templin C, Chen S.
Liao J, et al. Among authors: schratter a.
ESC Heart Fail. 2025 Apr;12(2):1271-1282. doi: 10.1002/ehf2.15136. Epub 2024 Nov 20.
ESC Heart Fail. 2025.
PMID: 39564882
Free PMC article.